Delivery Order SPE2DB24D1034-SPE2DB25FWAN6

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $1,659.74 and a period of performance through November 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract has a ceiling value of $1,633.35 and a period of performance through January 15, 2025. It is a firm fixed-price contract with no set-aside requirements, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Ambien CR 6.25 mg tablets, a prescription sleep medication, with a ceiling value of $1,068.03. This contract is not set aside for any specific business category. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award is a delivery order (SPE2DB25FVXZ9) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,657.54 firm-fixed-price contract is for the delivery of Ambien CR 6.25 mg tablets. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,427.97, is for the delivery of Ambien CR 12.5 mg tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of October 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,190.01 firm fixed-price contract is for the supply of Ambien CR 6.25 mg tablets, with a completion date of October 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds Indefinite Delivery Contracts (IDCs) with various federal agencies, including the DLA Troop Support Medical (up to $999,999,999) and the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Ambien CR 6.25 mg tablets in 100-count bottles, with a ceiling value of $1,712.74 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,556.01 firm fixed-price contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,656.43 firm fixed price contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,263.37 firm fixed-price delivery order is for the supply of Ambien CR 12.5 mg tablets, with a period of performance through January 17, 2025. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAN6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Ambien CR 12.5 mg tablets. The contract has a ceiling value of $1,086.02 and a period of performance through February 2025. It is a firm fixed-price contract, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/16/25, 12:35 PM